Bortezomib Stabilizes Mitotic Cyclins and Prevents Cell Cycle Progression via Inhibition of UBE2C in Colorectal Carcinoma

被引:61
|
作者
Bavi, Prashant [1 ]
Uddin, Shahab [1 ]
Ahmed, Maqbool [1 ]
Jehan, Zeenath [1 ]
Bu, Rong [1 ]
Abubaker, Jehad [1 ]
Sultana, Mehar [1 ]
Al-Sanea, Nasser [3 ]
Abduljabbar, Alaa [3 ]
Ashari, Luai H. [3 ]
Alhomoud, Samar [3 ]
Al-Dayel, Fouad [2 ]
Prabhakaran, Sarita [1 ]
Hussain, Azhar R. [1 ]
Al-Kuraya, Khawla S. [1 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Human Canc Genom Res Ctr, Res Ctr, Riyadh 11211, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Dept Surg, Colorectal Sect, Riyadh 11211, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Dept Pathol, Riyadh 11211, Saudi Arabia
来源
AMERICAN JOURNAL OF PATHOLOGY | 2011年 / 178卷 / 05期
关键词
UBIQUITIN-CONJUGATING ENZYME; PHASE KINASE PROTEIN-2; PROTEASOME INHIBITOR; UBCH10; EXPRESSION; THERAPEUTIC TARGET; COLON-CANCER; OVEREXPRESSION; DEGRADATION; TOOL; 5-FLUOROURACIL;
D O I
10.1016/j.ajpath.2011.01.034
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Substantial evidence implicates the ubiquitin-conjugating enzyme E2C (UBE2C) gene, in several human cancers, including colorectal carcinoma (CRC). We therefore investigated the prognostic value of UBE2C alterations in CRC and UBE2C signaling in CRC cell lines. UBE2C protein expression and UBE2C gene copy number were evaluated on clinical samples by immunohistochemistry and fluorescence in situ hybridization in a TMA format. The effect of the proteasome inhibitor bortezomib and small-interfering RNA knockdown was assessed by apoptotic assays and immunoblotting. UBE2C dysregulation was associated with proliferative marker Ki-67, accumulation of cyclin A and B1, and a poor overall survival. UBE2C expression was an independent prognostic marker in early-stage (I and II) CRC. UBE2C depletion resulted in suppression of cellular growth and accumulation of cyclin A and B1. In vitro, bortezomib treatment of CRC cells caused inhibition of cell viability via down-regulation of UBE2C. UBE2C knockdown by bortezomib or transfection with specific small-interfering RNA against UBE2C also caused cells to be arrested at the G2/M level, leading to accumulation of cyclin A and cyclin B1. In vivo, a significant reduction in tumor volume and weight was noted in mice treated with a combination of sub-toxic doses of oxaliplatin and bortezomib compared with treatment with oxaliplatin or bortezomib alone. Altogether, our results suggest that UBE2C and the ubiquitin-proteasome pathway may be potential targets for therapeutic intervention in CRC. (AmJ Pathol 2011, 178: 2109-2120; DOI: 10.1016/j.ajpath.2011.01.034)
引用
收藏
页码:2109 / 2120
页数:12
相关论文
共 50 条
  • [1] UBE2C promotes the progression of head and neck squamous cell carcinoma
    Jin, Zhenning
    Zhao, Xinyuan
    Cui, Li
    Xu, Xiangdong
    Zhao, Yutian
    Younai, Fariba
    Messadi, Diana
    Hu, Shen
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 523 (02) : 389 - 397
  • [2] The clinical significance of UBE2C gene in progression of renal cell carcinoma
    Chen, Zhiping
    Wang, Lanfeng
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2021, 65 (02):
  • [3] Clinico-pathological correlation of UBE2C alterations in colorectal carcinoma and efficacy of UBE2C inhibition by proteosome inhibitor as a viable therapeutic target
    Bu, Rong
    Bavi, Prashant
    Hussain, Azhar R.
    Jehan, Zeenath
    Abubaker, Jehad
    Al-Sanea, Nasser A.
    Abduljabbar, Alaa S.
    Ashari, Luai H.
    Al-Homoud, Samar J.
    Al-Dayel, Fouad
    George, Thara
    Qadri, Zeeshan
    Hassan, Nurul
    Prabhakaran, Sarita E.
    Ahmed, Magbool
    Uddin, Shahab
    Al-Kuraya, Khawla S.
    CANCER RESEARCH, 2011, 71
  • [4] UBE2C promotes malignancy of cutaneous squamous cell carcinoma
    Luo, Ruiting
    Bai, Ruimin
    Guo, Jiaqi
    Xian, Ningyi
    Zheng, Yan
    SKIN RESEARCH AND TECHNOLOGY, 2023, 29 (11)
  • [5] Nobiletin inhibits cell proliferation and invasion via suppression of UBE2C in hepatocellular carcinoma
    Su, Jinzhan
    Fan, Shufeng
    Su, Dongying
    Li, Miaoer
    Song, Xia
    SCIENCEASIA, 2024, 50 (05):
  • [6] UBE2C promotes rectal carcinoma via miR-381
    Zhang, Yan
    Tian, Suli
    Li, Xiaodong
    Ji, Yanchao
    Wang, Zhongcheng
    Liu, Chang
    CANCER BIOLOGY & THERAPY, 2018, 19 (03) : 230 - 238
  • [7] UBE2C Is a Transcriptional Target of the Cell Cycle Regulator FOXM1
    Nicolau-Neto, Pedro
    Palumbo, Antonio, Jr.
    De Martino, Marco
    Esposito, Francesco
    Simio, Tatiana de Almeida
    Fusco, Alfredo
    Nasciutti, Luiz Eurico
    Da Costa, Nathalia Meireles
    Ribeiro Pinto, Luis Felipe
    GENES, 2018, 9 (04):
  • [8] Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis
    Rong Li
    Xing-Feng Pang
    Zhi-Guang Huang
    Li-Hua Yang
    Zhi-Gang Peng
    Jie Ma
    Rong-Quan He
    BMC Cancer, 21
  • [9] UBE2C is a Potential Biomarker for Tumorigenesis and Prognosis in Tongue Squamous Cell Carcinoma
    Liu, Pei-Feng
    Chen, Chun-Feng
    Shu, Chih-Wen
    Chang, Hui-Min
    Lee, Cheng-Hsin
    Liou, Huei-Han
    Ger, Luo-Ping
    Chen, Chun-Lin
    Kang, Bor-Hwang
    DIAGNOSTICS, 2020, 10 (09)
  • [10] Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis
    Li, Rong
    Pang, Xing-Feng
    Huang, Zhi-Guang
    Yang, Li-Hua
    Peng, Zhi-Gang
    Ma, Jie
    He, Rong-Quan
    BMC CANCER, 2021, 21 (01)